Extraction
Qualified biomass moves through controlled extraction, filtration, and solvent-management discipline to create a stable upstream manufacturing input.
Manufacturing
Cilo Cybin offers GMP contract manufacturing services to licensed partners, connecting controlled cultivation, extraction, refinement, formulation, packaging, storage, and export-aware documentation under one regulated operating platform.
GMP operating premise
Cilo Cybin's manufacturing platform is built for licensed cannabis programs that require more than extraction alone. The route connects qualified source material, controlled processing, analytical review, formulation, packaging, storage, and release into one governed manufacturing system.
The emphasis is repeatability. Buyers need documented batch execution, traceable material movement, controlled environments, and finished outputs that are commercially usable for partner supply and destination-market review.
Manufacturing flow
These manufacturing stages are managed as one controlled operating chain rather than isolated technical steps.
Qualified biomass moves through controlled extraction, filtration, and solvent-management discipline to create a stable upstream manufacturing input.
Crude extracts can be purified through distillation and isolation where stronger potency control, narrower profiles, and cleaner handling are required.
Controlled cannabinoid inputs are translated into oils, tinctures, capsules, topicals, edibles, and other approved partner-ready dosage systems.
Filling, containment, and component handling are treated as governed manufacturing steps, not only as end-of-line presentation.
Batch coding, expiry control, labelling, leaflet insertion, and boxed-product completion support release-ready finished units.
Controlled storage, traceable handling, and export-aware documentation complete the commercial manufacturing pathway.
Upstream conversion
After source material release, the manufacturing value begins with disciplined extraction and carries into downstream purification. This part of the process determines impurity burden, solvent control, purification efficiency, and the consistency of the final cannabinoid product route.
For licensed buyers, that means the upstream manufacturing base is not judged only by output volume. It is judged by whether the process stays controlled, documented, and suitable for subsequent refinement, formulation, and release.
Manufacturing scale
Cilo Cybin supports GMP services across extraction, refinement, formulation, packaging, storage, and release of medical-grade cannabis products. Public operating material references the ability to process up to 20 litres of distillate per hour, positioning the platform for licensed commercial programs rather than laboratory-only work.
The real value is combining processing scale with release discipline, packaging execution, and destination-market documentation so product can move into partner supply chains without breaking the governed operating model.
Packaging and release
Cilo Cybin's manufacturing story extends into approved components, print verification, batch and expiry control, packed-product reconciliation, controlled storage, and export-aware documentation. Packaging is therefore treated as part of the GMP system rather than as a separate commercial afterthought.
This is where production becomes commercially meaningful for the buyer: the product must not only be manufactured correctly, it must also be presented, stored, and documented in a form that supports partner release and licensed supply.
Contract manufacturing enquiry
Share the intended product format, target market, documentation needs, and expected volumes so Cilo Cybin can recommend the right GMP manufacturing route.